MedTrace Logo

Liver Transplant for Larger Hepatocellular Carcinoma in Malatya: The Role of GGT and AFP

NCT04412161 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2020-06-02

No results posted yet for this study

Summary

Retrospective data on 50 prospectively-collected HCC patients with beyond-Milan criteria with \>6cm tumors were analyzed. 5-year OS of 76.2% was found in patients with both AFP \<200 ng/ml and GGT \<104 IU/mL with tumors less than 10 cm diameter. Thus, GGT values add to AFP in patient prognosis.

Conditions

Interventions

PROCEDURE

Liver transplantation

Living donor liver transplantation

Sponsors & Collaborators

  • Inonu University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-04-19
Primary Completion
2019-01-01
Completion
2019-12-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04412161 on ClinicalTrials.gov